Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01979003 · ClinicalTrials.gov registry record · Early Phase 1
Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion
A Early Phase 1 study, sponsored by University of Arkansas.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 100
- Enrollment target
NCT01979003 is a Early Phase 1 study that has completed, run by University of Arkansas. The registered enrollment target is 100 participants.
The verdict
NCT01979003, a Early Phase 1 study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 100 participants
- Enrollment target
Study Summary
To determine if Fluorescein systemic injection during hysterectomy procedure can be useful in revealing the depth of endometrial cancer invasion.
Interventions
- DRUG Fluorescein
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2014-09 |
| Est. Completion | 2021-06-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01979003
The ClinicalTrials.gov registry entry for NCT01979003 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluorescein is the first listed.
NCT01979003 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01979003 about?
NCT01979003 is a clinical study titled "Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion". To determine if Fluorescein systemic injection during hysterectomy procedure can be useful in revealing the depth of endometrial cancer invasion.
What is the current status of trial NCT01979003?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 100 participants. The study started on 2014-09. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT01979003?
The interventions under investigation include: Fluorescein (DRUG).
Who is sponsoring clinical trial NCT01979003?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.